Sharekhan

Anlon Healthcare Ltd

Mon 1/12/2025,9:59:40 NSE: AHCL

₹ 168.34 -0.27 (-0.16%)
BUY NOW Buy Anlon Healthcare Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Anlon Healthcare Ltd

Mon 1/12/2025,10:12:0

Anlon Healthcare Ltd

Mon 1/12/2025,9:59:40 | NSE : AHCL

₹ 168.34-0.27 (-0.16%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 169.96

Previous Close

₹ 168.61

Volume

40396

Mkt Cap ( Rs. Cr)

₹894.75

High

₹ 172.40

Low

₹ 165.25

52 Week High

₹ 172.75

52 Week Low

₹ 90.78

Book Value Per Share

₹ 17.63

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Anlon Healthcare Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

140.19

10932

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

10932

Option Chain

Analyzes market sentiment, predicts Anlon Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    28 Nov 2025, 5:41PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015 for Share Purchase Agreement executed between the Anlon Healthca

  • Anlon Healthcare - Others

    28 Nov 2025, 5:30PM With reference to the captioned subject, we would like to inform you that company has entered into a Share Purchase Agreement ( SPA ) with Bizotic Lif

  • Anlon Healthcare - Updates

    28 Nov 2025, 4:45PM The earlier copy of financial results was not in machine readable form. We have attached herewith revised copy in Machine readable form.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Nov 2025, 5:24PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    25 Nov 2025, 5:31PM We have attached herewith Intimation regarding Investor (s)/Analyst (s) meet.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.\r\n\r\n

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Nov 2025, 5:00PM Anlon Healthcare Limited has informed the Exchange about Transcript

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    24 Nov 2025, 5:13PM We have attached herewith Earning Call Transcript as per Reg. 30 (LODR), Regulations, 2015.\r\n\r\nKindly take same on your records.\r\n\r\nThanking Y

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    19 Nov 2025, 7:45PM We have attached herewith Outcome with call recording of Earning Conference Call with Multiple Investor(s) or Analyst (s).\r\n\r\nKindly take the same

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Nov 2025, 7:37PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Investor Presentation

    19 Nov 2025, 10:11AM Anlon Healthcare Limited has informed the Exchange about Investor Presentation

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 Nov 2025, 10:15AM We have attached herewith Investor Presentation.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Board Meeting Intimation for Consider General Business Matter.

    13 Oct 2025, 10:11PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 ,inter alia, to consider and

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    14 Nov 2025, 12:16PM We attached herewith Intimation of Earning Call Conference with Investor(s)/Analyst(s).\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Nov 2025, 12:09PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Copy of Newspaper Publication

    13 Nov 2025, 3:52PM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Monitoring Agency Report

    12 Nov 2025, 3:02PM Submission of Monitoring Agency Report for the quarter and half year ended September 30, 2025

  • Anlon Healthcare - Press Release

    12 Nov 2025, 12:08PM Anlon Healthcare Limited has informed the Exchange regarding a press release dated November 12, 2025, titled ""Press Release for the Financial Result

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    12 Nov 2025, 3:08PM We have attached herewith Monitoring Agency Report for the quarter and half year ended September 30, 2025.\r\n\r\nKindly take the same on your record.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    12 Nov 2025, 12:12PM We enclosed herewith press release as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Outcome of Board Meeting

    11 Nov 2025, 7:43PM Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

  • Anlon Healthcare - Related Party Transactions

    11 Nov 2025, 2:51PM Anlon Healthcare Limited has informed the Exchange about related Party Transactions

  • Anlon Healthcare - Statement of deviation(s) or variation(s) under Reg. 32

    11 Nov 2025, 2:50PM Anlon Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Anlon Healthcare - Integrated Filing- Financial

    11 Nov 2025, 2:49PM We have attached herewith Financial Results for the quarter/half year ended September 30, 2025.

  • Anlon Healthcare - Outcome of Board Meeting

    11 Nov 2025, 2:36PM Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Anlon Healthcare Q2 net profit zooms 259.85% at Rs 9.32 cr

    11 Nov 2025, 4:22PM The company reported standalone net profit of Rs 9.32 crore for the quarter ended September 30, 2025 as compared to Rs 2.59 crore in the same period l

  • Anlon Healthcare Q1 net profit down 5.59% at Rs 3.55 cr

    11 Nov 2025, 4:22PM The company reported standalone net profit of Rs 3.55 crore for the quarter ended June 30, 2025 as compared to Rs 3.76 crore in the same period last y

  • Anlon Healthcare - Statement Of Deviation & Variation

    11 Nov 2025, 3:13PM We have attached herewith statement of Deviation & Variation as per Reg. 32 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your recor

  • Anlon Healthcare - Financial Result For The Quarter And Half Year Ended September 30, 2025.

    11 Nov 2025, 3:00PM We have attached herewith financial result as per Reg. 30 and 33 of the SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\

  • Anlon Healthcare - Board Meeting Outcome for To Consider And Approve The Financial Result For The Quarter And Half Year Ended

    11 Nov 2025, 2:41PM We have attached herewith outcome of Board Meeting as per Reg. 30 and 33 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\

  • Anlon Healthcare - Board Meeting Intimation for Consider And Approve The Financial Results For The Quarter And Half Year Ende

    6 Nov 2025, 7:42PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and

  • Anlon Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, October 16, 2025

    16 Oct 2025, 8:02PM Respected Sir/Madam,\r\n\r\nWe have attached herewith Outcome of Board Meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Outcome of Board Meeting

    16 Oct 2025, 7:55PM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on October 16, 2025.

  • Anlon Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    16 Oct 2025, 10:00AM As of September 2025, 52.68% is owned by Indian Promoters and 47.32% by Public. <p align=justify> Institutional holds 2.83% (Insurance Companies 0.31%

  • Anlon Healthcare - Structural Digital Database

    14 Oct 2025, 2:37PM SDD COMPLIANCE CERTIFICATE AS PER REG. 3(5) AND 3(6) FOR THE QUARTER ENDED ON SEPTEMBER 30, 2025

  • Anlon Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Oct 2025, 2:26PM Anlon Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anlon Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Oct 2025, 2:57PM We have attached herewith Certificate as per Reg. 74(5) of SEBI (DP) Regulations, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Trading Window

    29 Sep 2025, 1:44PM Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Anlon Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, September 27, 2025

    27 Sep 2025, 7:36PM We have attached herewith outcome of Board Meeting held on Saturday, September 27, 2025.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Outcome of Board Meeting

    27 Sep 2025, 7:26PM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 27, 2025.

  • Anlon Healthcare - Board Meeting Intimation for Consider And Approve Proposal For Purchase Of Immovable Property.

    24 Sep 2025, 7:30PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/09/2025 ,inter alia, to consider and

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Sep 2025, 4:14PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 Sep 2025, 4:17PM We have attached herewith Intimation of Investor Meet as per Regulations 30 of SEBI (LODR) Regulations, 2015.\r\n\r\nKindly take the same on your reco

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Sep 2025, 3:49PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Sep 2025, 3:57PM We have attached herewith intimation of investor meet as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\

  • Anlon Healthcare - Updates

    20 Sep 2025, 3:14PM Anlon Healthcare Limited has informed the Exchange regarding 'Development of New Prodcuts '.

  • Anlon Healthcare - Announcement As Per Regulation 30 Of SEBI LODR, Regulations, 2015 For Development Of New Product.

    20 Sep 2025, 3:06PM We have enclosed herewith announcement as per Reg. 30 of SEBI LODR, Regulations, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Price movement

    18 Sep 2025, 9:47PM Significant movement in price has been observed in Anlon Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant info

  • Anlon Healthcare - Clarification On Price Movement Regarding Letter Received From L/SURV/ONL/PV/AJ/ 2025-2026 / 3092

    18 Sep 2025, 9:42PM We have attached herewith clarification letter regarding clarification on price movement.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you

  • Anlon Healthcare - Clarification sought from Anlon Healthcare Ltd

    18 Sep 2025, 7:11PM The Exchange has sought clarification from Anlon Healthcare Ltd on September 18, 2025 with reference to significant movement in price, in order to ens

  • Anlon Healthcare - Price movement

    18 Sep 2025, 6:40PM Significant movement in price has been observed in Anlon Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant info

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Sep 2025, 8:03PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    17 Sep 2025, 7:56PM We have attached herewith Intimation of Institutional Investors Meet/Research Analysts.\r\n\r\nYou are requested to take the above information on your

  • Anlon Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended September 03, 2025

    3 Sep 2025, 6:50PM As of September 2025, 52.68% is owned by Indian Promoters and 47.32% by Public. <p align=justify> Institutional holds 18.77% (Insurance Companies 0.81

  • Anlon Healthcare Ltd. debuts with 0.00% discount at Rs 91.00

    3 Sep 2025, 9:40AM Anlon Healthcare Ltd. makes a flat debut on the bourses with scrip got listed at Rs 91.00 on the Bombay Stock Exchange, a 0.00 per cent discount to it

  • Anlon Healthcare - Listing of Equity Shares of Anlon Healthcare Ltd

    3 Sep 2025, 8:12AM Trading Members of the Exchange are hereby informed that effective from September 03, 2025, the equity shares of Anlon Healthcare Ltd (Scrip Code: 544
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anlon Healthcare Ltd stock 

Name March-25 March-24 March-23
Assets 138.7691 95.5946 73.761
Liabilities 138.7691 95.5946 73.761
Equity 39.8515 16 12
Gross Profit 32.2087 15.4611 12.4148
Net Profit 20.5179 9.6571 5.82
Cash From Operating Activities -22.5517 -3.226 -2.8497
NPM(%) 17.05 14.5 5.15
Revenue 120.2866 66.5837 112.8774
Expenses 88.0779 51.1226 100.4626
ROE(%) 21.89 10.3 6.2

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anlon Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 795.10 0.28 0.00 95.28 301.39 0.63
Lotus Eye Hospital and Institute Ltd 105.10 -0.52 328.44 347.19 3.55 0.00
Vaishali Pharma Ltd 8.80 0.11 0.00 2178.06 3.13 0.00
Astec Lifesciences Ltd 820.00 -2.14 0.00 327.41 -604.77 0.00

Company Info

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.

Read More

Parent Organisation

Anlon Healthcare Ltd.

Founded

19/11/2013

Managing Director

Mr.Punitkumar R Rasadia

NSE Symbol

AHCLBE

FAQ

The current price of Anlon Healthcare Ltd is ₹ 168.34.

The 52-week high for Anlon Healthcare Ltd is ₹ 172.40 and the 52-week low is ₹ 165.25.

The market capitalization of Anlon Healthcare Ltd is currently ₹ 894.75. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anlon Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anlon Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anlon Healthcare Ltd shares.

The CEO of Anlon Healthcare Ltd is Mr.Punitkumar R Rasadia, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT